228 related articles for article (PubMed ID: 28281460)
1. Necrotising myopathy associated with anti-signal recognition particle (anti-SRP) antibody.
De Souza FHC; Miossi R; Shinjo SK
Clin Exp Rheumatol; 2017; 35(5):766-771. PubMed ID: 28281460
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
[TBL] [Abstract][Full Text] [Related]
3. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
[TBL] [Abstract][Full Text] [Related]
4. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series.
Valiyil R; Casciola-Rosen L; Hong G; Mammen A; Christopher-Stine L
Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1328-34. PubMed ID: 20506493
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients.
Suzuki S; Nishikawa A; Kuwana M; Nishimura H; Watanabe Y; Nakahara J; Hayashi YK; Suzuki N; Nishino I
Orphanet J Rare Dis; 2015 May; 10():61. PubMed ID: 25963141
[TBL] [Abstract][Full Text] [Related]
6. Myopathy with antibodies to the signal recognition particle: clinical and pathological features.
Miller T; Al-Lozi MT; Lopate G; Pestronk A
J Neurol Neurosurg Psychiatry; 2002 Oct; 73(4):420-8. PubMed ID: 12235311
[TBL] [Abstract][Full Text] [Related]
7. Treatment and outcomes in necrotising autoimmune myopathy: An Australian perspective.
Ashton C; Junckerstorff R; Bundell C; Hollingsworth P; Needham M
Neuromuscul Disord; 2016 Nov; 26(11):734-740. PubMed ID: 27665513
[TBL] [Abstract][Full Text] [Related]
8. Myopathy with anti-signal recognition particle antibodies: clinical and histopathological features in Chinese patients.
Wang L; Liu L; Hao H; Gao F; Liu X; Wang Z; Zhang W; Lv H; Yuan Y
Neuromuscul Disord; 2014 Apr; 24(4):335-41. PubMed ID: 24491486
[TBL] [Abstract][Full Text] [Related]
9. Immune-mediated necrotising myopathy in asymptomatic patients with high creatine kinase.
Soares IFZ; Comprido VF; Hsu BRRHS; Alves de Siqueira Carvalho A
BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33033004
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy reversed myopathy but not cardiomyopathy in a necrotizing autoimmune myopathy patient with positive anti-SRP and MDA-5 autoantibodies.
Ma X; Xu L; Li Y; Bu B
BMC Cardiovasc Disord; 2021 Feb; 21(1):88. PubMed ID: 33579193
[TBL] [Abstract][Full Text] [Related]
11. Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed.
Carvalho AAS; Silva VGD; Vieira TF; Delgado PO; Corazini R; Feder D; Fonseca FLA
Medicine (Baltimore); 2018 Aug; 97(35):e11858. PubMed ID: 30170376
[TBL] [Abstract][Full Text] [Related]
12. Anti-signal recognition particle autoantibody ELISA validation and clinical associations.
Aggarwal R; Oddis CV; Goudeau D; Fertig N; Metes I; Stephens C; Qi Z; Koontz D; Levesque MC
Rheumatology (Oxford); 2015 Jul; 54(7):1194-9. PubMed ID: 25524922
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.
Pinal-Fernandez I; Parks C; Werner JL; Albayda J; Paik J; Danoff SK; Casciola-Rosen L; Christopher-Stine L; Mammen AL
Arthritis Care Res (Hoboken); 2017 Feb; 69(2):263-270. PubMed ID: 27111848
[TBL] [Abstract][Full Text] [Related]
14. Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.
Benveniste O; Drouot L; Jouen F; Charuel JL; Bloch-Queyrat C; Behin A; Amoura Z; Marie I; Guiguet M; Eymard B; Gilbert D; Tron F; Herson S; Musset L; Boyer O
Arthritis Rheum; 2011 Jul; 63(7):1961-71. PubMed ID: 21400483
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study.
Picard C; Vincent T; Lega JC; Hue S; Fortenfant F; Lakomy D; Humbel RL; Goetz J; Molinari N; Bardin N; Bertin D; Johanet C; Chretien P; Dubucquoi S; Streichenberger N; Desplat-Jégo S; Bossuyt X; Sibilia J; Abreu I; Chevailler A; Fabien N
Immunol Res; 2016 Jun; 64(3):677-86. PubMed ID: 26744256
[TBL] [Abstract][Full Text] [Related]
16. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.
Aggarwal R; Moghadam-Kia S; Lacomis D; Malik A; Qi Z; Koontz D; Burlingame RW; Oddis CV
Scand J Rheumatol; 2020 Sep; 49(5):405-411. PubMed ID: 31801390
[No Abstract] [Full Text] [Related]
17. Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy.
Hengstman GJ; ter Laak HJ; Vree Egberts WT; Lundberg IE; Moutsopoulos HM; Vencovsky J; Doria A; Mosca M; van Venrooij WJ; van Engelen BG
Ann Rheum Dis; 2006 Dec; 65(12):1635-8. PubMed ID: 16679430
[TBL] [Abstract][Full Text] [Related]
18. Rituximab therapy in necrotizing autoimmune myopathy associated with anti-SRP antibody: A clinical case review.
Nóvoa Medina FJ; Gutiérrez Martínez J; González González Y; Romero Díaz B; Machín García S; Rosas Romero A
Reumatol Clin (Engl Ed); 2018; 14(6):379-381. PubMed ID: 28389200
[TBL] [Abstract][Full Text] [Related]
19. Anti-SRP auto-antibodies are not specific for myositis: Report of 8 cases.
Rodríguez-Muguruza S; Lozano-Ramos I; Coll-Canti J; Hernández-Gallego A; Ojanguren I; Martinez-Caceres E; Olive A
Joint Bone Spine; 2017 Jan; 84(1):103-105. PubMed ID: 27236258
[No Abstract] [Full Text] [Related]
20. Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature.
Cui BB; Tian YR; Ma XY; Yin G; Xie Q
Front Immunol; 2021; 12():777502. PubMed ID: 34925350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
